MedTrace Logo

Tart Cherry Supplementation & Gut Microbiome and Inflammation

NCT04467372 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 70

Last updated 2021-09-09

No results posted yet for this study

Summary

There has been a rapid increase in researching the use of tart cherry supplements in the past 5 years, particularly for inflammatory conditions. Many formulations of cherry supplements exist, however there has been no comparison between these different types. This is particularly important in the realm of inflammation research because sugar is known to increase the inflammatory response. The pill form of cherry supplementation has no added sugar and is naturally low in sugar (\< 1g) while the juice form is higher from added sugar. Recent work indicates tart cherry consumption can change gut microbiota, which may modify inflammation. The purpose of this study is to look at the effects of taking a cherry supplement, either in capsule or juice form, on the gut microbiome, inflammation, and health-related variables such as blood pressure, glucose regulation and sleep quality.

Conditions

Interventions

DIETARY_SUPPLEMENT

Tart cherry juice concentrate

Two 8oz bottles of tart cherry juice concentrate daily for 30 days

DIETARY_SUPPLEMENT

Juice placebo

Two 8oz bottles of placebo juice daily for 30 days

DIETARY_SUPPLEMENT

Freeze dried tart cherry powder

Two freeze dried tart cherry powder capsules daily for 30 days

DIETARY_SUPPLEMENT

Capsule placebo

Two placebo capsules daily for 30 days

Sponsors & Collaborators

  • Ohio University

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
BASIC_SCIENCE
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
55 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2019-03-18
Primary Completion
2019-10-16
Completion
2021-07-01

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04467372 on ClinicalTrials.gov